Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1624 1625 1626
This examiner grants 68% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18584298 | 3-AMINO PIPERIDYL SODIUM CHANNEL INHIBITORS | Non-Final OA | Genentech, Inc. |
| 18406937 | DINUCLEAR GOLD(I) COMPLEXES FOR TREATING CANCER | Non-Final OA | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS |
| 18673818 | Thieno[2,3-D]pyrimidin-4-one Derivatives as NMDAR Modulators and Uses Related Thereto | Non-Final OA | Emory University |
| 17911388 | METHODS OF CONTROLLING OR PREVENTING INFESTATION OF PLANTS BY THE PHYTOPATHOGENIC MICROORGANISM CORYNESPORA CASSIICOLA, CERCOSPORA SOJINA AND/OR CERCOSPORA KIKUCHII | Final Rejection | SYNGENTA CROP PROTECTION AG |
| 18366544 | OXA- IBOGAINE INSPIRED ANALOGUES FOR TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS | Non-Final OA | The Trustees of Columbia University in the City of New York |
| 18017000 | IBOGAINE ANALOGS AS THERAPEUTICS FOR NEUROLOGICAL AND PSYCHIATRIC DISORDERS | Final Rejection | The Trustees of Columbia University in the City of New York |
| 17938003 | KRATOM OPIOID DERIVATIVES FOR THE TREATMENT OF ALCOHOL USE DISORDER | Non-Final OA | The Trustees of Columbia University in the City of New York |
| 17758492 | TARGETED STEROID COMPOUNDS | Non-Final OA | Purdue Research Foundation |
| 18553909 | NAMPT ACTIVATORS FOR TREATING METABOLIC AND NEUROLOGICAL DISORDERS | Non-Final OA | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA |
| 18221936 | Cyclopentathiophene Carboxamide Derivatives as Platelet Activating Factor Receptor Antagonists | Non-Final OA | Boehringer Ingelheim International GmbH |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy